Yousuf A. Khan

Yousuf A. Khan

Auto-generated profile, based on publicly available information

Yousuf A. Khan

Department of Molecular and Cellular Physiology, Stanford University, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2024 in Nature
Verified
Journal Article
Open access
PDF file
JAJosh Abramson
Josh Abramson
JAJonas Adler
Jonas Adler
JDJack Dunger
Jack Dunger
RERichard Evans
Richard Evans
TGTim Green
Tim Green
JJJohn M. Jumper
John M. Jumper
The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2–6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues. The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein–ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein–nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody–antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework.

21 February 2025 in Science
Verified
Journal Article
Closed access
THThomas Hayes
Thomas Hayes
RRRoshan Rao
Roshan Rao
HAHalil Akin
Halil Akin
NSNicholas J. Sofroniew
Nicholas J. Sofroniew
DODeniz Oktay
Deniz Oktay
ARAlexander Rives
Alexander Rives
More than 3 billion years of evolution have produced an image of biology encoded into the space of natural proteins. Here, we show that language models trained at scale on evolutionary data can generate functional proteins that are far away from known proteins. We present ESM3, a frontier multimodal generative language model that reasons over the sequence, structure, and function of proteins. ESM3 can follow complex prompts combining its modalities and is highly responsive to alignment to improve its fidelity. We have prompted ESM3 to generate fluorescent proteins. Among the generations that we synthesized, we found a bright fluorescent protein at a far distance (58% sequence identity) from known fluorescent proteins, which we estimate is equivalent to simulating 500 million years of evolution.

27 November 2024 in Nature
Verified
Journal Article
Open access
PDF file
JAJosh Abramson
Josh Abramson
JAJonas Adler
Jonas Adler
JDJack Dunger
Jack Dunger
RERichard Evans
Richard Evans
TGTim Green
Tim Green
JJJohn M. Jumper
John M. Jumper

11 October 2021 in Critical Reviews in Biochemistry and Molecular Biology
Verified
Journal Article
Open access
YKYousuf A. Khan
Yousuf A. Khan
KWK. Ian White
K. Ian White
ABAxel T. Brunger
Axel T. Brunger
ATPases associated with diverse cellular activities (AAA+ proteins) are a superfamily of proteins found throughout all domains of life. The hallmark of this family is a conserved AAA+ domain responsible for a diverse range of cellular activities. Typically, AAA+ proteins transduce chemical energy from the hydrolysis of ATP into mechanical energy through conformational change, which can drive a variety of biological processes. AAA+ proteins operate in a variety of cellular contexts with diverse functions including disassembly of SNARE proteins, protein quality control, DNA replication, ribosome assembly, and viral replication. This breadth of function illustrates both the importance of AAA+ proteins in health and disease and emphasizes the importance of understanding conserved mechanisms of chemo-mechanical energy transduction. This review is divided into three major portions. First, the core AAA+ fold is presented. Next, the seven different clades of AAA+ proteins and structural details and reclassification pertaining to proteins in each clade are described. Finally, two well-known AAA+ proteins, NSF and its close relative p97, are reviewed in detail.

1 January 2017 in Molecular Cell
Verified
Journal Article
Closed access
SMSezen Meydan
Sezen Meydan
DKDorota Klepacki
Dorota Klepacki
SKSubbulakshmi Karthikeyan
Subbulakshmi Karthikeyan
TMTõnu Margus
Tõnu Margus
PTPaul M. Thomas
Paul M. Thomas
AMAlexander S. Mankin
Alexander S. Mankin

24 July 2017 in Leukemia
Verified
Journal Article
Open access
PDF file
TGT Girardi
T Girardi
SVS Vereecke
S Vereecke
SSS O Sulima
S O Sulima
YKY Khan
Y Khan
LFL Fancello
L Fancello
KKKim De Keersmaecker
Kim De Keersmaecker
Several somatic ribosome defects have recently been discovered in cancer, yet their oncogenic mechanisms remain poorly understood. Here we investigated the pathogenic role of the recurrent R98S mutation in ribosomal protein L10 (RPL10 R98S) found in T-cell acute lymphoblastic leukemia (T-ALL). The JAK-STAT signaling pathway is a critical controller of cellular proliferation and survival. A proteome screen revealed overexpression of several Jak-Stat signaling proteins in engineered RPL10 R98S mouse lymphoid cells, which we confirmed in hematopoietic cells from transgenic Rpl10 R98S mice and T-ALL xenograft samples. RPL10 R98S expressing cells displayed JAK-STAT pathway hyper-activation upon cytokine stimulation, as well as increased sensitivity to clinically used JAK-STAT inhibitors like pimozide. A mutually exclusive mutation pattern between RPL10 R98S and JAK-STAT mutations in T-ALL patients further suggests that RPL10 R98S functionally mimics JAK-STAT activation. Mechanistically, besides transcriptional changes, RPL10 R98S caused reduction of apparent programmed ribosomal frameshifting at several ribosomal frameshift signals in mouse and human Jak-Stat genes, as well as decreased Jak1 degradation. Of further medical interest, RPL10 R98S cells showed reduced proteasome activity and enhanced sensitivity to clinical proteasome inhibitors. Collectively, we describe modulation of the JAK-STAT cascade as a novel cancer-promoting activity of a ribosomal mutation, and expand the relevance of this cascade in leukemia.